Publications, Pharmaceutical

How pMDIs are transforming Asthma and COPD treatments

Pressurized metered dose inhalers have been used to treat asthma and COPD for over 60 years. However, the technologies within the pMDI container closure system and the drug and its formulation are very different and continue to evolve to meet patient needs, contain costs, and address changes in regulatory and environmental laws.  The immediate challenge to the Pharmaceutical industry however, is how to develop more sustainable pMDIs while at the same time, maintain patients adherence and compliance to their familiar treatment, lower the GWP of inhalers and to lower the overall carbon footprint of treatment.

This interview reviews some of these challenges and development timelines for new sustainable pMDIs as well as the discussion around dose counters in all future pressurized metered dose inhalers.

Download the publication on Dose and Delivery: How pMDIs are Transforming Asthma and COPD
Author(s): Chris Baron
12 Jul 2022

This article was taken from Pharmafile Summer 2022, page 22. Samedan Ltd

Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery

Find Out More About pulmonary drug delivery expertise

This Might Also Be of Interest

24 Apr 2024

Exploring Nasal Casts in Nasal Drug Development

Publications, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights

Read More
22 Apr 2024

Navigating the Shift to more sustainable Low GWP propellants in pMDIs

Publications, Pharmaceutical, Sustainability, Brand Differentiation, Market Insights, Product Solutions

Read More
26 Mar 2024

Optimizing Preclinical Studies for Intranasal and Pulmonary Programs

Webinars, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Market Insights, Product Solutions

Read More
13 Mar 2024

In Silico Modelling for Orally Inhaled Drug Development (OINDP)

Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions

Read More
1 2 3 4 … 20

Request Access

Close

Requesting access to How pMDIs are transforming Asthma and COPD treatments.

  • This field is for validation purposes and should be left unchanged.

How Can We Help?

Back To Top